TENX - TENAX THERAPEUTICS, INC.
5.36
-0.260 -4.851%
Share volume: 19,569
Last Updated: 05-06-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$5.62
-0.26
-0.05%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-13-2024 | 03-25-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | |||
| Operating expenses | 3.908 M | 3.672 M | 4.619 M | 0.000 | |
| Selling general and admin | 1.233 M | 1.344 M | 1.507 M | 0.000 | |
| Research and development | 2.676 M | 2.328 M | 3.112 M | 0.000 | |
| Total expenses | 3.908 M | 3.672 M | 4.619 M | 0.000 | |
| -6.05% | 25.79% | -100.00% | |||
| Operating income | -3.908 M | 3.672 M | 4.619 M | 0.000 | |
| Ebit | 0.000 | 0.000 | 0.000 | 0.000 | |
| Pretax income | -3.916 M | -3.577 M | -4.625 M | 0.000 | |
| -8.66% | 29.30% | -100.00% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -3.799 M | 3.576 M | 3.960 M | 0.000 | |
| 194.13% | 10.76% | -100.00% |
